LXRX
Lexicon Pharmaceuticals Inc
1.90$
-1.1%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +38.9% | -27.4% | -8.2% | -34.9% | +47.0% | -51.2% | -32.8% | +41.9% | +18.1% | +30.1% | -38.0% | |
| – | +44.3% | -32.8% | -10.0% | -46.2% | +94.9% | -53.3% | -43.6% | +58.4% | +25.3% | +39.4% | -58.6% | |
| – | +53.6% | -33.5% | -10.3% | -48.5% | -77.4% | +249.6% | -49.3% | -27.7% | -51.5% | +196.7% | -48.5% | |
| – | +53.6% | -33.5% | -10.3% | -48.5% | +69.7% | -43.9% | -43.0% | +59.5% | +22.9% | +40.0% | -59.6% | |
| – | -12.0% | +722.4% | -35.6% | +22.8% | +854.3% | -99.3% | -96.5% | +100.0% | +3,507.1% | +243.9% | -31.4% | |
| – | -100.0% | -100.0% | – | +140.2% | -9.3% | -100.0% | – | – | – | -39.4% | +21.6% | |
| – | +1,865.5% | -8.7% | -8.8% | -10.3% | -11.5% | -97.9% | +298.6% | +76.1% | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | +0.0% | +0.0% | -2.8% | -3.4% | -60.7% | – | – | – | – | – | – | |
| – | +96.9% | -13.8% | +20.8% | -19.2% | -3.2% | -84.2% | -50.8% | +231.0% | +76.6% | +11.8% | -49.2% | |
| – | +173.5% | +33.9% | -24.6% | -70.4% | +77.8% | -28.4% | -52.7% | +4.7% | +36.1% | +43.4% | -53.9% | |
| – | -326.7% | – | – | -798.8% | – | +5.5% | -91.1% | +18.5% | +0.0% | -9.0% | +430.8% | |
| – | +51.0% | +168.1% | -26.7% | -68.9% | +1.0% | -55.1% | +67.3% | +13.6% | +38.4% | +2.9% | -79.2% | |
| – | +18.6% | -17.9% | +171.9% | +5.3% | -4.0% | – | – | – | +104.8% | +0.8% | -50.7% | |
| – | +0.6% | -44.9% | -66.9% | -2,924.4% | – | +33.5% | -27.4% | +3.1% | -20.5% | +56.8% | -26.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +35.7% | +0.3% | +1.3% | +0.6% | +10.3% | -5.1% | +31.4% | +13.8% | +33.4% | +44.7% | +13.4% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.